・It is unclear what the company intends to charge for the vials, the report said. ・Unlike Novo, Eli Lilly and Company already sells its obesity drug Zepbound in both injector pen and vial formats.

It took decades to develop the first treatments to address the root causes of Alzheimer’s disease, and when they first reached patients, they weren’t exactly convenient to take. Patients have to visit ...

Wegovy (semaglutide) does come in a pill form. In December of 2025, the Food and Drug Administration (FDA) approved Wegovy as an oral tablet. Wegovy injections and tablets contain the same active ...

Novo Nordisk (NYSE: NVO) is taking investors on another rollercoaster ride. Last week, shares of the Danish pharmaceuticals stock tumbled as much as 27% on news that compounded pharmaceuticals firm ...

The price of Zepbound can vary depending on your insurance coverage, treatment plan, location, and chosen pharmacy. It’s important to check with your doctor, pharmacist, or insurance provider to ...

The Trump administration has rolled out a new website called TrumpRx, aimed at offering consumers lower prices on certain prescription drugs. The site, launched last week, lists discounted medications ...

Welcome to Camurus' Q4 Report 2025. [Operator Instructions] Now I'll hand the conference over to CEO, Fred Tiberg. Please go ahead. Thank you, Einar, and hello, everyone. Welcome to our fourth quarter ...

Earnings call Camurus reported FY2025 revenue of SEK 2.27B, up 21% YoY (30% at constant FX), with operating profit up 86% to SEK 874M. Brixadi royalties surged 87%, while Buvidal faced temporary FX ...

Hims & Hers Health announced it will sell Ozempic lookalike pills for $49 a month last week. The FDA objected Friday, and Novo Nordisk sued for patent infringement this morning. 10 stocks we like ...

Camurus AB reported its fourth-quarter 2025 earnings, revealing a notable decline in revenue and a subsequent sharp drop in its stock price. The company missed revenue forecasts, leading to a 19.1% ...